Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Evidence for the use of a nonsteroidal mineralocorticoid receptor antagonist for the treatment of chronic kidney disease Mariana Morais David Pliças, Bernardo Marques da Silva, Edgar Avito Fernandes de Almeida

Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen, Reem Sayad, Alyaa Khaled Abdelmonem, Katia Latifa, Lina Musallam, Moustafa Abouelkheir, Sherif Mira, Ahmed Awad, Ahmed Afsa, Waleed Nassar, Gehad El Ashal, Mohamed Elmasry, Eshak I. Bahbah